Orbimed Advisors - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 73 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2021$7,525,000
-15.6%
1,452,7740.0%0.10%
-1.0%
Q3 2021$8,920,000
-42.9%
1,452,774
-6.1%
0.10%
-38.0%
Q2 2021$15,622,0001,546,7000.16%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders